NCT00757679View on ClinicalTrials.gov

Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

PHASE2CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Fibromyalgia Syndrome
Interventions
DRUG

Milnacipran

capsules

DRUG

Placebo

capsules

Trial Locations (1)

Unknown

Clinical Pharmacology & Toxicology Multidisciplinary Pain Centre, Geneva

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT00757679 - Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran | Biotech Hunter | Biotech Hunter